glp-1 reviews receptor agonists for individualized treatment of type 2 diabetes mellitus Scam weight-loss drops marketed to

There have been and continue to be advances in the GLP-1 pipeline.

Discover the transformative impact of GLP-1 agonists, originally a diabetes treatment, on thousands of peoples weight-loss journey.

Tirzepatide displayed an unprecedented glucose and body weight lowering potential, presenting also with the ability to increase insulin sensitivity, reduce systolic blood pressure and inflammation and ameliorate dyslipidemia, particularly by reducing triglycerides levels

Jardiance (empagliflozin) 38% CV death reduction vs Mounjaro (tirzepatide) 21% weight loss (EMPA-REG vs SURPASS)

GLP-1 is a hormone your body makes

Our licensed providers create custom treatment plans based on your unique goals and health history, with ongoing telehealth support every step of the way